Saturday 17 October 2026
Export CNSP’s income statement to Excel — free account
CNS Pharmaceuticals, Inc.
CNSP Healthcare Biotechnology
In the quarter to June 2026, EPS grew 94.1% and free cash flow grew 33.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.85
0.33
−6.37%
Follow CNSP
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.73 | 0.48 | 25.38 | 8.13 | 2.88 | 2.55 | 0.26 | 3.43 | 1.98 |
Net Debt/EBITDA |
(0.05) | 0.32 | 1.90 | 1.49 | 0.35 | 0.66 | 0.03 | 0.43 | 0.45 |
Debt/Assets |
0.00% | 41.26% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(2.08) | (0.51) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.51 | 0.10 | 0.92 | 0.77 | 0.93 | 0.69 | 0.75 | 1.15 | 0.87 |
Capex/Depreciation |
— | 0.00 | (1.00) | (1.61) | (0.44) | (0.37) | (0.95) | (1.27) | (4.67) |
Interest Coverage |
(100.05) | (30.83) | (146.30) | (2,865.03) | (1,557.62) | (2,181.01) | (1,367.04) | (925.58) | (1,051.75) |
| 72.19% | 2,432.35% | (109.96%) | (87.78%) | (144.15%) | (213.68%) | (1,018.76%) | (1,703.39%) | (296.30%) | |
| (51.90%) | (2,163.59%) | (90.22%) | (79.59%) | (117.80%) | (140.06%) | (255.54%) | (285.68%) | (182.99%) | |
ROIC |
0.00% | 0.00% | (665.82%) | 0.00% | (781.37%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
375.04% | 1,146.92% | (51.01%) | (69.47%) | (295.86%) | (199.66%) | 415.51% | (241.98%) | (394.33%) |
Average Days of Receivables |
— | — | — | — | — | — | — | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.20) | (7,164.00) | (17,868.00) | (36,679.50) | 0.00 | 0.00 | (70,719.50) | (534.92) | (31.22) |
Cash per Share |
0.20 | 5,551.00 | 36,206.50 | 70,197.50 | 0.00 | 0.00 | 2,743.50 | 201.92 | 16.26 |
Shareholders Equity per Share |
(0.11) | (5,493.00) | 38,005.50 | 69,740.00 | 0.00 | 0.00 | (22,160.50) | 193.02 | 10.21 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.11) | (5,493.00) | 38,005.50 | 69,740.00 | 0.00 | 0.00 | (22,160.50) | 193.02 | 10.21 |
Free Cash Flow |
(0.11) | (0.72) | (3.57) | (7.34) | (13.54) | (10.56) | (14.14) | (17.12) | (13.83) |
Working Capital |
(0.06) | (0.64) | 7.58 | 13.59 | 4.88 | 7.64 | (4.54) | 6.13 | 4.00 |
Capital Expenditures |
— | — | (0.02) | (0.02) | (0.01) | 0.00 | 0.00 | 0.00 | (0.02) |
Net Current Asset Value |
(0.06) | (0.64) | 7.58 | 13.59 | 4.88 | 7.64 | (4.54) | 6.13 | 4.00 |
| Other line items | |||||||||
Quick Ratio |
0.50 | 0.45 | 23.28 | 7.37 | 1.93 | 2.04 | 0.09 | 2.91 | 1.76 |
Depreciation/Fixed assets |
— | 0.00 | 1.10 | 0.47 | 0.81 | 2.07 | 0.84 | 0.55 | 0.22 |
Cash ROIC |
(64.56%) | (249.01%) | (24.08%) | (26.21%) | (121.28%) | (58.07%) | 364.21% | (135.44%) | (117.96%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.20) | (7,164.00) | (17,767.50) | (36,590.00) | 0.00 | 0.00 | (70,700.00) | (534.79) | (31.18) |
Capex per Share |
0.00 | 0.00 | (100.50) | (89.50) | 0.00 | 0.00 | (19.50) | (0.13) | (0.04) |
Average Payables |
0.09 | 0.09 | 0.21 | 0.62 | 1.46 | 3.25 | 5.17 | 4.02 | 2.99 |
Average Assets |
0.42 | 0.34 | 4.30 | 11.88 | 12.31 | 10.91 | 7.38 | 5.20 | 8.66 |
Average Common Equity |
(0.30) | (0.30) | 3.53 | 10.77 | 10.06 | 7.15 | 1.85 | 0.87 | 5.35 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates